SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19
Top Cited Papers
- 10 May 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 73 (4), 807-816
- https://doi.org/10.1016/j.jhep.2020.05.002
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case seriesBMJ, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- SARS-associated viral hepatitis caused by a novel coronavirus: Report of three casesJournal of Hepatology, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- A Major Outbreak of Severe Acute Respiratory Syndrome in Hong KongThe New England Journal of Medicine, 2003
- A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong KongThe New England Journal of Medicine, 2003
- Identification of Severe Acute Respiratory Syndrome in CanadaThe New England Journal of Medicine, 2003